Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells

Toshifumi Hara, Matthew F. Jones, Murugan Subramanian, Xiao Ling Li, Oliver Ou, Yuelin Zhu, Yuan Yang, Lalage M. Wakefield, S. Perwez Hussain, Jochen Gaedcke, Thomas Ried, Ji Luo, Natasha J. Caplen, Ashish Lal

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.

Original languageEnglish
Pages (from-to)7635-7650
Number of pages16
JournalOncotarget
Volume5
Issue number17
DOIs
Publication statusPublished - 1 Jan 2014

    Fingerprint

Keywords

  • Colorectal cancer
  • KRAS
  • KRAS mutant
  • miR-126
  • miRNA

ASJC Scopus subject areas

  • Oncology

Cite this

Hara, T., Jones, M. F., Subramanian, M., Li, X. L., Ou, O., Zhu, Y., Yang, Y., Wakefield, L. M., Perwez Hussain, S., Gaedcke, J., Ried, T., Luo, J., Caplen, N. J., & Lal, A. (2014). Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells. Oncotarget, 5(17), 7635-7650. https://doi.org/10.18632/oncotarget.2284